Literature DB >> 24894406

Catastrophic antiphospholipid syndrome presenting with pulmonary hemorrhage: case report.

Tony Wan1, Peter Tsang.   

Abstract

This is a case report of catastrophic antiphospholipid syndrome (APLS) involving the rare manifestation of pulmonary hemorrhage. This rare variant of APLS is frequently life threatening despite medical therapy. The pathogenesis of pulmonary hemorrhage in catastrophic APLS remains incompletely understood. The optimal approach to managing pulmonary hemorrhage in the setting of catastrophic APLS is still unclear, however this case report demonstrates the success of combination therapy with anticoagulation, corticosteroids and plasma exchange.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24894406     DOI: 10.1007/s11239-014-1089-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  8 in total

Review 1.  Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review.

Authors:  Kevin D Deane; Sterling G West
Journal:  Semin Arthritis Rheum       Date:  2005-12       Impact factor: 5.532

2.  Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'.

Authors:  R Cervera
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

Review 3.  Catastrophic antiphospholipid syndrome (CAPS).

Authors:  Savino Sciascia; Chary Lopez-Pedrera; Dario Roccatello; Maria Jose' Cuadrado
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-08       Impact factor: 4.098

4.  Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report.

Authors:  A Al Rashidi; M Alajmi; M O Hegazi
Journal:  Lupus       Date:  2011-08-09       Impact factor: 2.911

5.  "Possible primary antiphospholipid syndrome" with concurrent diffuse alveolar hemorrhaging and Libman-Sacks endocarditis mimicking catastrophic antiphospholipid syndrome.

Authors:  Akitake Suzuki; Naoki Asazuma; Eigo Kikuchi; Takeshi Kawanobe; Yoshihiko Horimoto; Ryuichi Yokobari; Shigeru Kotake; Takahiro Okai
Journal:  Intern Med       Date:  2012-04-01       Impact factor: 1.271

6.  The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.

Authors:  Ulas D Bayraktar; Doruk Erkan; Silvia Bucciarelli; Gerard Espinosa; Ronald Asherson
Journal:  J Rheumatol       Date:  2007-02       Impact factor: 4.666

7.  Catastrophic antiphospholipid syndrome presented with abdominal, pulmonary, and bone marrow complications.

Authors:  Badira F Makhoul; Ludmila Guralnik; Zaher S Azzam
Journal:  Rheumatol Int       Date:  2009-05-18       Impact factor: 2.631

Review 8.  Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.

Authors:  R A Asherson; R Cervera; P G de Groot; D Erkan; M C Boffa; J C Piette; M A Khamashta; Y Shoenfeld
Journal:  Lupus       Date:  2003       Impact factor: 2.911

  8 in total
  1 in total

Review 1.  Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.

Authors:  Sarah Abramson Stoots; Lindsay Lief; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2019-09-06       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.